← back to search

Cristina Garibaldi

European Institute of Oncology ·
Area of research
Radiation · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Advanced Radiotherapy Techniques, Medical Imaging Techniques and Applications, Advances in Oncology and Radiotherapy, and Prostate Cancer Diagnosis and Treatment.
h-index
31
citations
2,804
works
199
NIH funding
primary concept
email

Recent publications

Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma—a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology
The Lancet Oncology 2024cited by 34position: middledoi
Minimum and optimal requirements for a safe clinical implementation of ultra-high dose rate radiotherapy: A focus on patient’s safety and radiation protection
Radiotherapy and Oncology 2024cited by 15position: firstdoi
Results of 2023 survey on the use of synthetic computed tomography for magnetic resonance Imaging-only radiotherapy: Current status and future steps
Physics and Imaging in Radiation Oncology 2024cited by 9position: middledoi
Real-time motion management in MRI-guided radiotherapy: Current status and AI-enabled prospects
Radiotherapy and Oncology 2023cited by 38position: middledoi
The influence of basic plan parameters on calculated small field output factors – A multicenter study
Physica Medica 2021cited by 4position: middledoi
EP-1708 Organ motion impact on dose delivered with non-coplanar VMAT for lung SBRT
Radiotherapy and Oncology 2019cited by 0position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

· 3 papers (2021–2024) · 2 papers (2023–2024)Paige A. Taylor · The University of Texas Health Science Center at Houston1 papers (2024–2024)Till T. Böhlen · Institute of Radiation Physics1 papers (2024–2024)P. Bagalà · Università Campus Bio-Medico1 papers (2021–2021) · 1 papers (2021–2021)Verdi Vanreusel · University of Antwerp1 papers (2024–2024) · 1 papers (2021–2021) · 1 papers (2019–2019) · 1 papers (2019–2019)Luise A. Künzel · German Cancer Research Center1 papers (2023–2023) · 1 papers (2021–2021)M. Stasi · Imperial College Healthcare NHS Trust1 papers (2021–2021) · 1 papers (2019–2019) · 1 papers (2019–2019) · 1 papers (2021–2021)F. Pansini · European Institute of Oncology1 papers (2019–2019) · 1 papers (2024–2024)Charoula Iliaskou · University Medical Center Freiburg1 papers (2024–2024) · 1 papers (2024–2024)